Wedbush maintains Rocket Pharmaceuticals PT at $15.00
Wedbush maintained its $15.00 per-share price target for Rocket Pharmaceuticals,
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.